Ascension Seton Medical Center
- Type
- Teaching hospital
- Where
- Austin, TX
- Medicare CCN
- 450056
- Received
- $505,149 in 163 records, 2023 ($111,994 general, $393,154 research)
- Source
- CMS Open Payments search ↗
On this site
- Nonprofit contractor: ASCENSION SETON MEDICAL CENTER Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2023 | General payment | 21 | $111,994 |
| 2023 | Research payment | 142 | $393,154 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Medtronic, Inc. | 50 | $177,734 | 2023 |
| Abbott Laboratories | 39 | $52,599 | 2023 |
| ABBVIE INC. | 1 | $50,000 | 2023 |
| Alexion Pharmaceuticals, Inc. | 1 | $44,676 | 2023 |
| AngioDynamics, Inc. | 2 | $43,000 | 2023 |
| InspireMD Ltd | 1 | $34,737 | 2023 |
| Esperion Therapeutics, Inc. | 9 | $22,866 | 2023 |
| Terumo Medical Corporation | 4 | $20,340 | 2023 |
| United Therapeutics Corporation | 1 | $9,950 | 2023 |
| BIOTRONIK INC. | 22 | $9,774 | 2023 |
| KLS-Martin L.P. | 3 | $9,487 | 2023 |
| Aimmune Therapeutics, Inc. | 5 | $8,979 | 2023 |
| Veryan Medical Incorporated | 4 | $7,682 | 2023 |
| UCB SA | 1 | $5,450 | 2023 |
| Mirum Pharmaceuticals, Inc. | 4 | $2,275 | 2023 |
| Galderma Research & Development, LLC | 1 | $1,500 | 2023 |
| Mylan Specialty L.P. | 1 | $1,200 | 2023 |
| Straumann USA LLC | 1 | $1,113 | 2023 |
| Merge Healthcare Incorporated | 9 | $630 | 2023 |
| Travere Therapeutics, Inc. | 2 | $600 | 2023 |
| Stryker Corporation | 2 | $551 | 2023 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 142 | $393,154 |
| Education | 1 | $50,000 |
| Long term medical supply or device loan | 4 | $43,551 |
| Debt forgiveness | 6 | $16,612 |
| Space rental or facility fees (teaching hospital only) | 1 | $1,200 |
| Food and Beverage | 9 | $630 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | AngioDynamics, Inc. | $30,000 | Long term medical supply or device loan | In-kind items and services | Auryon Laser System 100-120 Vac Device, ET | 2023 | |
| 2023-12-31 | AngioDynamics, Inc. | $13,000 | Long term medical supply or device loan | In-kind items and services | Solero Device, Oncology | 2023 | |
| 2023-12-31 | Stryker Corporation | $535 | Long term medical supply or device loan | In-kind items and services | PRIME Device, PATIENT HANDLING - PH | 2023 | |
| 2023-12-31 | Stryker Corporation | $16 | Long term medical supply or device loan | In-kind items and services | ULTRA COMFORT SURFACE Device, PATIENT HANDLING - PH | 2023 | |
| 2023-12-21 | Medtronic, Inc. | $500 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2023 |
| 2023-12-20 | Aimmune Therapeutics, Inc. | $3,423 | Research payment | Cash or cash equivalent | ARC008 | 2023 | |
| 2023-12-19 | Mirum Pharmaceuticals, Inc. | $1,000 | Research payment | Cash or cash equivalent | Chenodal Drug, Hepatology | A PHASE 3 STUDY TO EVALUATE THE EFFECTS OF CHENODAL IN ADULT AND PEDIATRIC PATIENTS WITH CEREBROTENDINOUS XANTHOMATOSIS | 2023 |
| 2023-12-19 | Mirum Pharmaceuticals, Inc. | $675 | Research payment | Cash or cash equivalent | Chenodal Drug, Hepatology | A PHASE 3 STUDY TO EVALUATE THE EFFECTS OF CHENODAL IN ADULT AND PEDIATRIC PATIENTS WITH CEREBROTENDINOUS XANTHOMATOSIS | 2023 |
| 2023-12-15 | Abbott Laboratories | $500 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-12-14 | Medtronic, Inc. | $7,390 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-12-13 | Abbott Laboratories | $45 | Research payment | In-kind items and services | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-12-13 | Abbott Laboratories | $35 | Research payment | In-kind items and services | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-12-11 | Medtronic, Inc. | $1,250 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-12-11 | Abbott Laboratories | $500 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-12-03 | Mylan Specialty L.P. | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Tobi Podhaler Drug, Aminoglycosides | 2023 | |
| 2023-12-01 | United Therapeutics Corporation | $9,950 | Research payment | Cash or cash equivalent | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RALINEPAG WHEN ADDE | 2023 | |
| 2023-11-22 | Abbott Laboratories | $500 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-11-22 | Abbott Laboratories | $250 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-11-21 | Medtronic, Inc. | $3,600 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2023 |
| 2023-11-20 | Abbott Laboratories | $7,263 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-11-17 | Merge Healthcare Incorporated | $129 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2023 | |
| 2023-11-15 | Merge Healthcare Incorporated | $35 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2023 | |
| 2023-11-14 | Merge Healthcare Incorporated | $150 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2023 | |
| 2023-11-13 | Medtronic, Inc. | $6,210 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-11-07 | Straumann USA LLC | $1,113 | Debt forgiveness | Cash or cash equivalent | 2023 | ||
| 2023-11-07 | Mirum Pharmaceuticals, Inc. | $300 | Research payment | Cash or cash equivalent | Chenodal Drug, Hepatology | A PHASE 3 STUDY TO EVALUATE THE EFFECTS OF CHENODAL IN ADULT AND PEDIATRIC PATIENTS WITH CEREBROTENDINOUS XANTHOMATOSIS | 2023 |
| 2023-11-07 | BIOTRONIK INC. | $55 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-10-30 | Abbott Laboratories | $320 | Research payment | Cash or cash equivalent | XIENCE SIERRA Device, Vascular | A Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as | 2023 |
| 2023-10-26 | Abbott Laboratories | $11,500 | Research payment | Cash or cash equivalent | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-10-17 | Medtronic, Inc. | $8,197 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-10-10 | Medtronic, Inc. | $875 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | CoreValve SURTAVI | 2023 |
| 2023-10-10 | Medtronic, Inc. | $875 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | CoreValve SURTAVI | 2023 |
| 2023-09-30 | Veryan Medical Incorporated | $1,676 | Research payment | Cash or cash equivalent | BioMimics 3D Vascular Stent System Device, Vascular Stent | A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of p | 2023 |
| 2023-09-30 | Veryan Medical Incorporated | $500 | Research payment | Cash or cash equivalent | BioMimics 3D Vascular Stent System Device, Vascular Stent | A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of p | 2023 |
| 2023-09-28 | Abbott Laboratories | $1,500 | Research payment | Cash or cash equivalent | XIENCE SIERRA Device, Vascular | A Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as | 2023 |
| 2023-09-28 | Abbott Laboratories | $700 | Research payment | Cash or cash equivalent | XIENCE SIERRA Device, Vascular | A Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as | 2023 |
| 2023-09-28 | Terumo Medical Corporation | $50 | Research payment | Cash or cash equivalent | OSPREY ILIAC: OCCLUSIVE/STENOTIC PERIPHERAL ARTERY REVASCULARIZATION STUDY FOR COMMON AND/OR EXTERNAL ILIAC ARTERY USING | 2023 | |
| 2023-09-19 | Medtronic, Inc. | $3,750 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-09-12 | Medtronic, Inc. | $1,000 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-09-12 | Mirum Pharmaceuticals, Inc. | $300 | Research payment | Cash or cash equivalent | Chenodal Drug, Hepatology | A PHASE 3 STUDY TO EVALUATE THE EFFECTS OF CHENODAL IN ADULT AND PEDIATRIC PATIENTS WITH CEREBROTENDINOUS XANTHOMATOSIS | 2023 |
| 2023-09-11 | Abbott Laboratories | $124 | Research payment | Cash or cash equivalent | Confirm Rx Device, Cardiac Rhythm Management | Confirm Rx Insertable Cardiac Monitor SMART Registry | 2023 |
| 2023-08-31 | BIOTRONIK INC. | $5,405 | Debt forgiveness | Cash or cash equivalent | 2023 | ||
| 2023-08-31 | BIOTRONIK INC. | $605 | Debt forgiveness | Cash or cash equivalent | 2023 | ||
| 2023-08-29 | Abbott Laboratories | $90 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-08-29 | Abbott Laboratories | $90 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-08-23 | Terumo Medical Corporation | $5,600 | Research payment | Cash or cash equivalent | OSPREY ILIAC: OCCLUSIVE/STENOTIC PERIPHERAL ARTERY REVASCULARIZATION STUDY FOR COMMON AND/OR EXTERNAL ILIAC ARTERY USING | 2023 | |
| 2023-08-21 | Abbott Laboratories | $379 | Research payment | Cash or cash equivalent | Confirm Rx Device, Cardiac Rhythm Management | Confirm Rx Insertable Cardiac Monitor SMART Registry | 2023 |
| 2023-08-18 | Medtronic, Inc. | $5,961 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-08-17 | Medtronic, Inc. | $6,210 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-08-14 | Medtronic, Inc. | $3,050 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2023 |
| 2023-08-14 | Abbott Laboratories | $709 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-08-14 | Abbott Laboratories | $150 | Research payment | Cash or cash equivalent | XIENCE SIERRA Device, Vascular | A Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as | 2023 |
| 2023-08-07 | Abbott Laboratories | $400 | Research payment | Cash or cash equivalent | CARDIOMEMS Device, Heart Failure | Hemodynamic-GUIDEd Management of Heart Failure | 2023 |
| 2023-08-04 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-08-04 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-08-04 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-08-04 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-08-01 | Abbott Laboratories | $45 | Research payment | In-kind items and services | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-08-01 | Abbott Laboratories | $35 | Research payment | In-kind items and services | MITRACLIP Device, Vascular | Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients with PrImary Mitral Regurgitation Who Are Cand | 2023 |
| 2023-07-27 | KLS-Martin L.P. | $4,795 | Debt forgiveness | Cash or cash equivalent | IPS,MODEL, SKULL, FULL, CRYSTAL,QTY:001 EA Device, Osteosynthesis | 2023 | |
| 2023-07-27 | KLS-Martin L.P. | $3,620 | Debt forgiveness | Cash or cash equivalent | IPS,MARKING GUIDE, W/PLANNING, TRANSFORM,QTY:001 EA Device, CT Based Planning | 2023 | |
| 2023-07-27 | KLS-Martin L.P. | $1,071 | Debt forgiveness | Cash or cash equivalent | IPS,SUPPLEMENTAL MODEL, TRANSFORM, HALF,QTY:001 EA Device, CT Based Planning | 2023 | |
| 2023-07-25 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | Confirm Rx Device, Cardiac Rhythm Management | Confirm Rx Insertable Cardiac Monitor SMART Registry | 2023 |
| 2023-07-18 | Travere Therapeutics, Inc. | $300 | Research payment | Cash or cash equivalent | Chenodal Drug, Hepatology | A PHASE 3 STUDY TO EVALUATE THE EFFECTS OF CHENODAL IN ADULT AND PEDIATRIC PATIENTS WITH CEREBROTENDINOUS XANTHOMATOSIS | 2023 |
| 2023-07-13 | Abbott Laboratories | $1,400 | Research payment | Cash or cash equivalent | XIENCE SIERRA Device, Vascular | A Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as | 2023 |
| 2023-07-10 | BIOTRONIK INC. | $286 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-07-10 | Veryan Medical Incorporated | $165 | Research payment | Cash or cash equivalent | BioMimics 3D Vascular Stent System Device, Vascular Stent | A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of p | 2023 |
| 2023-07-10 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-07-10 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-07-10 | BIOTRONIK INC. | $134 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-07-10 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-07-10 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-07-06 | Medtronic, Inc. | $10,805 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-07-06 | Abbott Laboratories | $1,250 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-06-28 | Medtronic, Inc. | $1,785 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2023 |
| 2023-06-22 | Abbott Laboratories | $5,750 | Research payment | Cash or cash equivalent | CARDIOMEMS Device, Heart Failure | Hemodynamic-GUIDEd Management of Heart Failure | 2023 |
| 2023-06-22 | Abbott Laboratories | $800 | Research payment | Cash or cash equivalent | CARDIOMEMS Device, Heart Failure | Hemodynamic-GUIDEd Management of Heart Failure | 2023 |
| 2023-06-13 | Abbott Laboratories | $500 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-06-07 | Medtronic, Inc. | $18,940 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-06-07 | Abbott Laboratories | $500 | Research payment | Cash or cash equivalent | XIENCE SIERRA Device, Vascular | A Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as | 2023 |
| 2023-06-07 | Abbott Laboratories | $250 | Research payment | Cash or cash equivalent | Confirm Rx Device, Cardiac Rhythm Management | Confirm Rx Insertable Cardiac Monitor SMART Registry | 2023 |
| 2023-06-02 | BIOTRONIK INC. | $500 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-05-31 | Medtronic, Inc. | $500 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-05-25 | Esperion Therapeutics, Inc. | $6,000 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2023 |
| 2023-05-25 | Galderma Research & Development, LLC | $1,500 | Research payment | Cash or cash equivalent | A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With M | 2023 | |
| 2023-05-25 | Abbott Laboratories | $1,000 | Research payment | Cash or cash equivalent | CARDIOMEMS Device, Heart Failure | Hemodynamic-GUIDEd Management of Heart Failure | 2023 |
| 2023-05-25 | Abbott Laboratories | $750 | Research payment | Cash or cash equivalent | Confirm Rx Device, Cardiac Rhythm Management | Confirm Rx Insertable Cardiac Monitor SMART Registry | 2023 |
| 2023-05-25 | Esperion Therapeutics, Inc. | $500 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2023 |
| 2023-05-25 | Esperion Therapeutics, Inc. | $500 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2023 |
| 2023-05-23 | Esperion Therapeutics, Inc. | $10,618 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2023 |
| 2023-05-17 | Abbott Laboratories | $4,074 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-05-17 | Esperion Therapeutics, Inc. | $32 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2023 |
| 2023-05-16 | Medtronic, Inc. | $3,250 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2023 |
| 2023-05-11 | Abbott Laboratories | $500 | Research payment | Cash or cash equivalent | ENSITE PRECISION Device, Electrophysiology | A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World E | 2023 |
| 2023-05-11 | Abbott Laboratories | $40 | Research payment | Cash or cash equivalent | ENSITE PRECISION Device, Electrophysiology | A Clinical Evaluation Using EnSite Precision Cardiac Mapping System (Software Version 2.0.1 or Higher) in a Real-World E | 2023 |
| 2023-05-04 | Terumo Medical Corporation | $13,490 | Research payment | Cash or cash equivalent | OSPREY ILIAC: OCCLUSIVE/STENOTIC PERIPHERAL ARTERY REVASCULARIZATION STUDY FOR COMMON AND/OR EXTERNAL ILIAC ARTERY USING | 2023 | |
| 2023-05-04 | Terumo Medical Corporation | $1,200 | Research payment | Cash or cash equivalent | OSPREY ILIAC: OCCLUSIVE/STENOTIC PERIPHERAL ARTERY REVASCULARIZATION STUDY FOR COMMON AND/OR EXTERNAL ILIAC ARTERY USING | 2023 | |
| 2023-05-03 | Abbott Laboratories | $855 | Research payment | Cash or cash equivalent | Confirm Rx Device, Cardiac Rhythm Management | Confirm Rx Insertable Cardiac Monitor SMART Registry | 2023 |
| 2023-05-02 | Medtronic, Inc. | $8,818 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-05-01 | InspireMD Ltd | $34,737 | Research payment | Cash or cash equivalent | CGuard Device, cardiology | Safety and Efficacy of the CGuard Carotid Stent System in Carotid Artery Stenting | 2023 |
| 2023-04-18 | BIOTRONIK INC. | $250 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-04-17 | Medtronic, Inc. | $1,170 | Research payment | Cash or cash equivalent | INFUSE BONE GRAFT Device, Bone Matrix/Graft | TLIF IDE Pivotal Study | 2023 |
| 2023-04-17 | Medtronic, Inc. | $860 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2023 |
| 2023-04-17 | Medtronic, Inc. | $860 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2023 |
| 2023-04-11 | Merge Healthcare Incorporated | $32 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2023 | |
| 2023-04-10 | Merge Healthcare Incorporated | $69 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2023 | |
| 2023-03-30 | Medtronic, Inc. | $880 | Research payment | Cash or cash equivalent | INFUSE BONE GRAFT Device, Bone Matrix/Graft | TLIF IDE Pivotal Study | 2023 |
| 2023-03-21 | Medtronic, Inc. | $5,370 | Research payment | Cash or cash equivalent | INFUSE BONE GRAFT Device, Bone Matrix/Graft | TLIF IDE Pivotal Study | 2023 |
| 2023-03-21 | Medtronic, Inc. | $2,500 | Research payment | Cash or cash equivalent | INFUSE BONE GRAFT Device, Bone Matrix/Graft | TLIF IDE Pivotal Study | 2023 |
| 2023-03-21 | Medtronic, Inc. | $1,928 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-21 | Medtronic, Inc. | $1,928 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-21 | Medtronic, Inc. | $484 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-21 | Medtronic, Inc. | $484 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-21 | Medtronic, Inc. | $484 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-21 | Medtronic, Inc. | $484 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-21 | Medtronic, Inc. | $484 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-21 | Medtronic, Inc. | $134 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-21 | Medtronic, Inc. | $134 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-15 | BIOTRONIK INC. | $175 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-03-15 | BIOTRONIK INC. | $134 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-03-14 | ABBVIE INC. | $50,000 | Education | Cash or cash equivalent | 2023 | ||
| 2023-03-09 | Esperion Therapeutics, Inc. | $2,125 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2023 |
| 2023-03-09 | Esperion Therapeutics, Inc. | $2,000 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2023 |
| 2023-03-09 | Esperion Therapeutics, Inc. | $1,000 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2023 |
| 2023-03-07 | Medtronic, Inc. | $6,500 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-07 | Medtronic, Inc. | $1,443 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-07 | Medtronic, Inc. | $1,310 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-07 | Medtronic, Inc. | $1,310 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-07 | Medtronic, Inc. | $1,310 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-07 | Medtronic, Inc. | $1,310 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-07 | Medtronic, Inc. | $948 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-07 | Medtronic, Inc. | $948 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-03-07 | Medtronic, Inc. | $923 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-02-28 | Medtronic, Inc. | $3,167 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-02-23 | Aimmune Therapeutics, Inc. | $1,125 | Research payment | Cash or cash equivalent | ARC008 | 2023 | |
| 2023-02-23 | Aimmune Therapeutics, Inc. | $900 | Research payment | Cash or cash equivalent | ARC008 | 2023 | |
| 2023-02-23 | Aimmune Therapeutics, Inc. | $225 | Research payment | Cash or cash equivalent | ARC008 | 2023 | |
| 2023-02-20 | Merge Healthcare Incorporated | $117 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2023 | |
| 2023-02-17 | Aimmune Therapeutics, Inc. | $3,305 | Research payment | Cash or cash equivalent | ARC008 | 2023 | |
| 2023-02-15 | Abbott Laboratories | $4,843 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-02-15 | Abbott Laboratories | $620 | Research payment | Cash or cash equivalent | SJM MASTERS SERIES Device, Structural Heart | A Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as | 2023 |
| 2023-02-14 | BIOTRONIK INC. | $175 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-02-14 | BIOTRONIK INC. | $175 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-02-14 | BIOTRONIK INC. | $162 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-02-14 | BIOTRONIK INC. | $82 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-02-09 | Medtronic, Inc. | $7,203 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-02-09 | UCB SA | $5,450 | Research payment | Cash or cash equivalent | Vimpat Drug, Neurology | A MULTICENTER, OPEN-LABEL, RANDOMIZED, ACTIVE COMPARATOR STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF | 2023 |
| 2023-02-09 | Medtronic, Inc. | $3,788 | Research payment | Cash or cash equivalent | REVEAL LINQ Device, Cardiac Diagnostics and Monitoring | Define AFib | 2023 |
| 2023-02-08 | Abbott Laboratories | $1,952 | Research payment | Cash or cash equivalent | Confirm Rx Device, Cardiac Rhythm Management | Confirm Rx Insertable Cardiac Monitor SMART Registry | 2023 |
| 2023-02-07 | Travere Therapeutics, Inc. | $300 | Research payment | Cash or cash equivalent | Chenodal Drug, Hepatology | A Phase 3 Study to Evaluate the Effects of Chenodeoxycholic Acid in Adult and Pediatric Patients With Cerebrotendinous X | 2023 |
| 2023-01-31 | Alexion Pharmaceuticals, Inc. | $44,676 | Research payment | Cash or cash equivalent | A PHASE 4 RANDOMIZED CLINICAL TRIAL OF ANDEXANET ALFA, ANDEXANET ALFA FOR INJECTION, IN ACUTE INTRACRANIAL HEMORRHAGE IN | 2023 | |
| 2023-01-31 | BIOTRONIK INC. | $650 | Research payment | Cash or cash equivalent | Orsiro Mission Device, Cardiology/Vascular Diseases | BIOFLOW-VII | 2023 |
| 2023-01-27 | Medtronic, Inc. | $5,750 | Research payment | Cash or cash equivalent | FLOWMET-R Device, Intraprocedural Monitoring | FlowMet-R for PAD and CLI | 2023 |
| 2023-01-27 | Medtronic, Inc. | $750 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2023 |
| 2023-01-19 | Abbott Laboratories | $1,125 | Research payment | Cash or cash equivalent | Confirm Rx Device, Cardiac Rhythm Management | Confirm Rx Insertable Cardiac Monitor SMART Registry | 2023 |
| 2023-01-17 | Medtronic, Inc. | $1,500 | Research payment | Cash or cash equivalent | INFUSE BONE GRAFT Device, Bone Matrix/Graft | TLIF IDE Pivotal Study | 2023 |
| 2023-01-13 | Abbott Laboratories | $250 | Research payment | Cash or cash equivalent | AMPLATZER TALISMAN Device, Structural Heart | AMPLATZER PFO Occluder Post Approval Study | 2023 |
| 2023-01-12 | Medtronic, Inc. | $28,411 | Research payment | Cash or cash equivalent | COREVALVE EVOLUT R Device, Transcatheter Valve Systems | SMART Trial | 2023 |
| 2023-01-12 | Merge Healthcare Incorporated | $9 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2023 | |
| 2023-01-11 | Merge Healthcare Incorporated | $70 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2023 | |
| 2023-01-11 | Merge Healthcare Incorporated | $15 | Food and Beverage | Cash or cash equivalent | Software Device, Medical Imaging | 2023 | |
| 2023-01-03 | Esperion Therapeutics, Inc. | $90 | Research payment | Cash or cash equivalent | NEXLETOL Drug, ANTILIPEMIC AGENTS | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC | 2023 |
| 2023-01-01 | Veryan Medical Incorporated | $5,340 | Research payment | Cash or cash equivalent | BioMimics 3D Vascular Stent System Device, Vascular Stent | A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of p | 2023 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Austin, TX, county Travis County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Austin, TX | County Travis County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 979,539 | 1,330,015 | 30,188,424 |
| Population, 2020 census P1 | 961,855 | 1,290,188 | 29,145,505 |
| Median age B01002 | 34.7 | 35.6 | 35.6 |
| Under 18 B01001 | 18.0% | 20.2% | 25.0% |
| 65 and over B01001 | 10.4% | 11.0% | 13.4% |
| Households B11001 | 456,113 | 583,747 | 10,992,816 |
| Foreign born B05002 | 18.7% | 18.1% | 17.6% |
| Median household income B19013 | $93,658 | $99,611 | $78,476 |
| Median family income B19113 | $128,808 | $131,256 | $94,599 |
| Per capita income B19301 | $62,862 | $62,607 | $40,752 |
| Poverty rate B17001 | 12.0% | 10.9% | 13.8% |
| Unemployment rate B23025 | 4.7% | 4.6% | 5.3% |
| Civilian labor force B23025 | 617,774 | 799,524 | 15,233,563 |
| Mean commute (minutes) B08013 | 23.7 | 25.2 | 26.7 |
| Bachelor's degree or higher B15003 | 59.6% | 56.6% | 33.8% |
| Housing units B25001 | 483,071 | 618,236 | 12,128,515 |
| Owner-occupied B25003 | 43.4% | 52.1% | 62.6% |
| Renters B25003 | 56.6% | 47.9% | 37.4% |
| Median home value B25077 | $555,300 | $523,000 | $283,800 |
| Median gross rent B25064 | $1,729 | $1,744 | $1,403 |
| White, not Hispanic B03002 | 47.0% | 46.9% | 39.1% |
| Black B03002 | 7.3% | 7.8% | 11.9% |
| Hispanic or Latino B03002 | 31.9% | 32.6% | 39.7% |
| Asian B03002 | 9.0% | 7.8% | 5.5% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Austin, TX.
Comments